Evidence from randomised controlled trials supports beneficial effects of total dairy products on body weight, fat and lean mass, but evidence on associations of dairy types with distributions of body fat and lean mass is limited. We aimed to investigate associations of total and different types of dairy products with markers of adiposity, and body fat and lean mass distribution. We evaluated cross-sectional data from 12,065 adults aged 30 to 65 years recruited to the Fenland study between 2005 and 2015 in Cambridgeshire UK. Diet was assessed with a food frequency questionnaire. We estimated regression coefficients (or % differences) and their 95% CI using multiple linear regression models. The median (interquartile range) of milk, yoghurt, and cheese consumption were 293 (146 -439), 35.3 (8.8 -71.8), and 14.6 (4.8 -26.9) g/d, respectively. Low-fat dairy consumption was inversely associated with visceral-to-subcutaneous fat ratio estimated with dual energy X-ray absorptiometry [-2.58% (-3.91, -1.23%) per serving/day]. Habitual consumption per serving/day (200 g) of milk was associated with 0.33 (0.19, 0.46) kg higher lean mass. Other associations were not significant after false discovery correction. Our findings suggest that the influence of milk consumption on lean mass and of low-fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk.
Introduction
Diet is acknowledged to be a leading behavioural risk factor for cardio-metabolic diseases (1) .
Among dietary factors, dairy products are of particular interest due to their inverse association with cardio-metabolic health(2), thought to be related to their high nutrient density and mineral content, but also due to the controversy arising from their blood cholesterol raising saturated fat content(3).
Several meta-analyses of prospective cohort studies on the associations of dairy products with cardiovascular disease (4, 5) and type 2 diabetes (6) (7) (8) have suggested that the associations vary by dairy type. There is a general concordance of observational results suggesting an inverse association between yoghurt consumption and type 2 diabetes (6) (7) (8) . In contrast, evidence for associations between other dairy types and type 2 diabetes (7, 9) or cardiovascular disease(4) is inconsistent with either null or inverse associations reported for the consumption of cheese and low-fat milk (4, 7, 9) .
Adiposity is one of the most well described potential pathways which might link total dairy consumption to cardio-metabolic disease pathogenesis. Evidence from randomised clinical trials shows that total dairy products decrease body weight (10) and body fat mass (10) , and increase body lean mass (11) under energy restriction. However, evidence on associations between types of dairy products and markers of adiposity, especially markers of fat and lean mass distribution is sparse.
Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SCAT) are compartments of abdominal fat. While abdominal fat is associated with cardio-metabolic diseases (12) , VAT has been more strongly associated with cardio-metabolic risk than SCAT (13) , which has been suggested to be potentially protective (14) . Specifically the ratio of VAT to SCAT was reported to be strongly associated with cardio-metabolic risk independent of body mass index (BMI) and VAT (15) . Due to the higher cost of the methods to estimate abdominal fat distribution e.g. dual energy X-ray absorptiometry (DEXA), most large-scale population studies examine waist circumference as a proxy for abdominal fat, which cannot fully capture the distribution between VAT and SCAT. Only a few studies have investigated associations between dairy products (total(16) and low-fat(17)) and VAT, but evidence is lacking on associations of dairy consumption with SCAT and VAT/SCAT.
We aimed to investigate the associations of total and different types of dairy products with body fat and lean mass and their distribution in a large population-based study in the UK.
Methods

Study design and population
The Fenland study is a cohort study with baseline measurements conducted between 2005 and 2015 (n=12,434 with 27% response rate). Eligible participants were born between 1950 and 1975 and were invited via their general practice to attend the clinical sites at Ely, Wisbech, or Cambridge, UK, where the clinical and dietary assessments were conducted. Exclusion criteria, assessed by general practitioners, were known history of diabetes, psychotic or terminal illness, inability to walk unaided, pregnancy, or lactation. The study was approved by the Cambridge Local Ethics Committee. All participants gave written informed consent. For the current analysis, we evaluated baseline data from 12,065 participants after exclusion of pregnant women (n=5), participants with missing dietary data (n=17), those in the bottom and top 1% of total energy intake (n=250), and in the top 1% of total dairy consumption (n=97).
Participants with missing outcome data were also excluded (n range=1-812 depending on the outcome). A study flowchart of participant inclusion is presented in Figure 1 .
Dietary assessment
Participants' diet over the previous year was assessed with a 130-item semi-quantitative food frequency questionnaire (18) . The dietary data were processed using FETA software (19) . Dairy products were assessed in servings/d and were categorised as we previously described(20) ( Table   1) . Dairy servings were defined as one average glass (200 g) for milk, 125 g pot for yoghurt, a medium serving of 40 g for cheese, one tablespoon (15 g) for single cream, one tablespoon (30 g) for double cream, one teaspoon (10 g) for butter and one average scoop/tub (60 g) for ice-cream.
Adiposity measures
These measurements were conducted at each clinical site according to standardised procedures.
BMI was calculated as weight divided by height squared (kg /m 2 ). Waist and hip circumferences were averaged from two repeated measures with a non-stretch tape. Total body fat and its distribution (peripheral fat, VAT, SCAT) and lean mass and its distribution (appendicular lean mass) were estimated with a DEXA scan (Lunar Prodigy Advanced fan beam scanner, GE Healthcare, Bedford, United Kingdom; GE encore software, version 14.10.022 to 16, GE Medical
Systems (21)). Specifically, the DEXA system demarcated the boundaries of the android region based on an established protocol. VAT was estimated as part of the android region from an inbuilt algorithm of the DEXA software. SCAT was calculated after subtracting VAT from the android fat mass. These DEXA estimates of abdominal VAT and SCAT have been validated against amounts of VAT and SCAT determined by computed tomography (22) and magnetic resonance imaging(23), the reference methods for adipose tissue quantification. (25) . This method was previously validated with doubly-labelled water.
Statistical analyses
As primary exposures, we considered milk, yoghurt and cheese. As primary outcome, we defined the ratio of VAT to SCAT (VAT/SCAT). Other outcomes included total and peripheral body fat mass, total and appendicular body lean mass and proxies of abdominal fat i.e. waist circumference and the waist-to-hip ratio. We presented results for VAT/SCAT as %change after backtransformation (exponentiation) of the log-transformed variable, because it was positively-skewed.
Missing covariates were imputed by chained equations under the assumption of data missing at random (26) . Multiple imputation involved linear, logistic and predictive mean matching models according to variable distribution and five imputation datasets were derived. Further analyses accounted for variability due to imputation. To examine cross-sectional associations between different dairy types and adiposity markers, robust multiple linear regression was used, deriving multiple maximum likelihood (MM-)estimators, which are robust against the influence of outliers (27) . The initial probability of false positive findings was set to 5%. Because of the large number of tests, false discovery rate correction was applied accounting for correlations between tests(28). Associations were considered significant if they passed this correction (P<0.0005).
Associations were adjusted for potential confounders based on previous knowledge and biological plausibility. Specifically, we adjusted for socio-demographic, lifestyle and clinical factors including age, sex, test-site, ethnicity, age at completion of full-time education, education level, occupation, household income, marital status, smoking status, pack-years of smoking, physical activity energy expenditure, hormone-replacement therapy (for women only), lipid-lowering medication, antihypertensive medication (categorical), plasma vitamin C (as a marker of diet quality, reflecting fruit and vegetable intake), dietary supplement use, total energy intake, consumption of dietary factors (fruit, vegetables not including potatoes, potatoes, legumes, processed cereals, whole-grain cereals, poultry and eggs, red meat, processed meat, fish, sauces, margarine, nuts, sweet snacks, sugar- sweetened beverages, artificially sweetened beverages, fruit juice, regular coffee, decaffeinated coffee, tea, alcoholic beverages), and BMI. Adjustment for BMI was performed to (1) examine associations independent of BMI, (2) partly account for the possibility of dietary misreporting and (3) account for lifestyle confounding due to obesity status. Dairy types were mutually adjusted.
When the outcome was lean mass, models were further adjusted for height.
Pre-specified tests for effect modification by sex and BMI for each association were investigated.
As sensitivity analyses, we repeated regression analyses in the complete-case dataset, to examine stability of results based on five imputed datasets in the primary analyses. To assess whether nonlinear associations were present, restricted cubic spline regressions (three knots at the 10 th , 50 th and 90 th percentiles) were fitted in the most adjusted model above. For the same purpose, categorical exposures were used with five categories including non-consumers and quartiles among consumers for types of dairy products. Quartiles were generated from the residuals of the regression of total energy intake against dairy products (29) . In addition to the analyses including BMI as a covariate,
we also adjusted for the ratio of total energy intake to basal metabolic rate as an indicator of dietary misreporting (30) . In post-hoc analyses, we examined whether the identified significant associations can be explained by nutrients contained in dairy products including calcium, potassium, magnesium, phosphorus, vitamin A, vitamin B12, lactose, mono-unsaturated fat and saturated fat from the dairy exposure one-by-one. All analyses were conducted using Stata 14.2 (College Station, TX: StataCorp LP, 2015).
Results
Descriptive characteristics
We evaluated 12,065 adults (53.8% women) with a mean (SD) age of 48.8 (7.5) years ( Table 2) .
Almost two-thirds of high yoghurt consumers were women. Participants of non-white ethnic background were more frequently low dairy consumers compared with participants of white ethnic background. The ethnic difference was most marked for cheese intake: the percentage of non-white participants among non-consumers of cheese was 6.3% higher than among cheese consumers.
Yoghurt and cheese consumption was positively associated with higher socio-economic status and negatively associated with likelihood of being current smokers (Supplemental Table 1 ). Among dairy consumption levels, overall, low-fat dairy consumption was approximately seven times higher than that of high-fat dairy (Supplemental Table 1 ). Table   2 ). Similar associations were observed for low-fat milk and for low-fat and total dairy products.
Low-fat dairy consumption was associated with 2.6% lower (-3.91, -1.23%) VAT/SCAT. A similar association was observed for VAT (Supplemental Figure 1) . Other dairy types were not significantly associated with BMI, nor any dairy products with any other anthropometric measure (Figures 2 and 3, Supplemental Figure 1 ).
Other analyses
Results were not altered when complete-case analyses were performed, and findings were similar when adjusting for the ratio of total energy intake to basal metabolic rate rather than adjusting for BMI or after further adjustment for dairy nutrients (Supplemental Table 3 ). There was no indication of a non-linear association from analyses with restricted cubic splines or categorical exposures after correction for multiple testing.
Discussion
Our study reports two main findings. The first was that habitual daily consumption of one serving of low-fat dairy products was associated with a 3% lower ratio of VAT to SCAT as a marker of fat mass distribution, a measure which is associated with diabetes risk independently of total fat mass (15) . Second, habitual daily consumption of 1 serving of milk was associated with a 0.33 kg higher body lean mass. There are no previous studies on the association between dairy consumption and VAT/SCAT. A randomized controlled trial showed a reduction in VAT among those consuming 6-7 servings of dairy products per day compared to those consuming less than 4 servings/d(16), and a crosssectional study of twins reported an inverse association between low-fat fermented dairy products and VAT(17), but we have not identified any studies of the association between dairy consumption and SCAT. Although total dairy consumption has been consistently associated with a lower body fat mass in randomized controlled trials (31) (32) (33) , the number of studies for dairy subtypes is limited.
We found no significant associations between any dairy type and total or peripheral fat mass or waist circumference and waist-to-hip ratio as proxies for fat mass distribution. The direction of the associations we observed between low-fat dairy consumption and total body fat mass, and waist circumference was consistent with the findings of previous studies and with our findings for VAT/SCAT. The higher dairy amounts used in feeding trials compared to the consumption levels reported in observational studies could partly explain the lack of significance in certain associations.
In addition, it is expected that the direction of the association of low-fat dairy products with VAT/SCAT is consistent with that of the association of low-fat dairy with waist circumference and the waist-to-hip ratio, because waist circumference is a proxy measure of abdominal fat.
VAT/SCAT was estimated with higher accuracy than waist and hip circumferences. This might partly explain as to why the association with VAT/SCAT was significant after multiple test correction, but not the association with waist circumference and the waist-to-hip ratio.
No mechanism has been reported for an inverse association between low-fat dairy consumption and VAT/SCAT. Nevertheless, a plausible explanation could be that VAT is more metabolically active with a more efficient glucose uptake than SCAT (34) , and therefore the effects of dairy nutrients on fat mass are more pronounced in the VAT than in SCAT. Among dairy nutrients, calcium may reduce the fat content of the adipose tissue because intracellular calcium promotes lipolysis and reduces lipogenesis(35) and calcium supplementation was previously shown to decrease VAT without changing body weight or total abdominal fat(36).
With our analyses and specifically the observed positive association between milk consumption and body lean mass, we extend the previous understanding on the positive association between total dairy consumption and total lean mass(31) to include specific dairy subtypes. Dairy products and mainly milk have been consistently associated with bone health due to their nutrients content including calcium, phosphorous, vitamin D and protein, which might partly explain the positive association with lean mass (37) . Another potential mechanism is the increasing effect of milk on growth hormone(38, 39), which has been associated with a higher lean mass through a higher bone mineral density and muscle mass (40) . 
Strengths and limitations
Our study has several strengths including its large sample size (n=12,065), and the inclusion of several dairy subtypes, which allowed the investigation of potentially different associations with adiposity for different dairy types. By employing DEXA, we were able to use more accurate methods to assess VAT and SCAT than previous studies that used waist circumference and waistto-hip ratio as proxies of central adiposity (12) . Our statistical approaches were thorough including the adjustment for important potential confounders including objectively measured physical activity, the derivation of estimates robust to outliers, and the handling of missing data with multiple imputation.
Our study also has limitations. The cross-sectional design increases the risk of reverse causation and limits inference for causal association and our results can thus be used mainly for hypothesis generation. Although the food frequency questionnaire used was assessed for validity in a similar
population (18) and we adjusted for BMI as an established factor of dietary misreporting (41), we cannot exclude the possibility of error due to dietary misreporting caused by the use of self-reported methods of dietary assessment. Commensurate with this, the food frequency questionnaire was limited in the detail on types of dairy products consumed, so we were not able to estimate the nutrient content accurately and thus made assumptions based on average estimates. The questionnaire also limited the assessment of various dairy definitions (e.g. sweetened yoghurt) and the influences of such variations on study results. Although we adjusted for many potential confounders, residual confounding cannot be ruled out. We were also not able to disentangle whether BMI was a confounder, a mediator or both in our cross-sectional analysis, while we could examine the associations independent of BMI. If BMI is on the causal pathway adjustment for BMI would have attenuated the findings towards the null. Future prospective analyses of change in weight (or BMI) in relation to dairy products will be better placed to investigate this further. The response rate of our study was moderate at 27%. This should be placed in the context of the internal validity of our study with our use of objective assessments i.e. DEXA on the full cohort, but we acknowledge limited external validity (generalisability) of our findings for the UK general population. Moreover, our population was largely white European, who overall consume higher amounts of dairy products compared to other populations especially in South Asia, South America and Africa (42) , so generalisability of our results to other ethnic groups with different consumption patterns might be limited. Specifically, consumption of different dairy groups has a limited range in our study, with low levels of high-fat dairy products and high levels of low-fat dairy products. This might compromise the power to detect associations across a broader range of dairy consumption, which might be seen in other populations. 
Conclusion
We observed an inverse association between low-fat dairy products and the ratio of visceral to subcutaneous fat, which suggests that abdominal obesity may be a potential pathway for the association of dairy consumption with cardio-metabolic disease. In addition, the observed association of higher milk consumption with a higher body lean mass could also be a potential explanation for the overall metabolic associations observed for dairy consumption. These findings are important for hypothesis-generation and should stimulate further investigation in prospective studies, clinical trials and mechanistic studies of the link between dairy products and cardiometabolic disease. *The variables derived directly from the FFQ questions were used †The variable derived directly from the FFQ questions on hard cheese intake was used. The assumption made here is that high-fat cheese is equivalent to hard cheese. ‡The variable derived directly from the FFQ questions on cottage and low-fat soft cheese intake was used. The assumption made here is that low-fat cheese is equivalent to cottage and low-fat, soft cheese. §Cream was used as a contributor to high-fat and total dairy products, but results separately for it and its types are not presented, as the very low intakes result in very unstable and imprecise estimates 
